Current Trends in Cardiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Case Report - Current Trends in Cardiology (2020) Volume 4, Issue 2

Myocarditis in an HIV-infected patient with Covid-19.

Emanuela Lattuada1*, Romualdo Mazzi 1, Elena Carrara 1, Michela Conti 1, Cattaneo Paolo 1, Massimiliano Lanzafame2, Evelina Tacconelli 1, Sandro Vento3

1Unita Complessa di Malattie Infettive, University of Verona, Verona, Italy

2Unita Semplice Organizzativa "Diagnosi e Terapia dell' infezione da HIV", University of Verona, Verona, Italy

3Department of Medicine, University of Puthisasthra, Phnom Penh, Cambodia

Corresponding Author:
Emanuela Lattuada
Infectious Diseases Unit
Azienda Ospedaliera Verona piazzale Ludovico Scuro
Verona Italy

Accepted date: September 04, 2020

Citation: Lattuada E, Mazzi R, Carrara E, et al . Myocarditis in an HIV-infected patient with Covid-19. Curr Trend Cardiol 2020;4(2):70.

Visit for more related articles at Current Trends in Cardiology


COVID-19 can cause myocarditis with complex possible pathophysiology. A case of acute myocarditis in an HIV-infected patient with COVID-19 has been reported here. The patient’s condition progressively improved after proper treatment. But still we have to observe many different cases to get the full picture of COVID-19 in HIV-coinfected people.


Myocaridits, Cardiac MRI, Pulmonary hypertension.


We report a case of acute myocarditis in an HIV-infected patient with COVID-19. In the Emergency Department, the patient had a positive nasopharyngeal swab for SARS-CoV-2; pO2 was 66 mmHg and pCO2 36 mmHg. White blood cells(13,000/ μL; N 9,000; L2,200), CRP (108 mg/dL), LDH (336 IU/L) and creatinine (175 μmol/L) were increased. A chest X-ray was apparently normal, while an electrocardiogram showed atrial premature complexes, diffuse inverted T waves in lateral leads, and prolonged QT interval. Troponin levels were 52, 516 and 1,583 ng/L (normal<14 ng/L) at three successive tests, and an echocardiogram showed left ventricular hypertrophy. Myocarditis and pericarditis were diagnosed [1,2]. The patient was admitted to the Intensive Care Unit and treated with enoxaparine 6,000 IU bid, acetylsalicylic acid 250 mg as loading dose, prednisone 25 mg, doxazosin 4 mg, amlodipine 10 mg and hydroxychloroquine 400 mg bid as loading dose, and then 200 mg bid [3-6]. Rilpivirine was stopped and lopinavir/ritonavir added to his antiretroviral regimen. Oxygen therapy with Venturi mask at a 35% FiO2 setting was started. Blood cultures were negative as well as urinary legionella and pneumococcal antigens. Serology for parvovirus B19 and enterovirus was negative, and cytomegalovirus, herpesviruses, Epstein-Barr virus were negative by polymerase chain reaction [7].


The patient’s condition progressively improved. Troponine decreased to 475 ng/L over six days, and a new echocardiogram did not show any changes and did not reveal any vegetations on cardiac valves. The patient was transferred to our Department for follow-up, nine days after admission; his blood pressure remained high and a third echocardiogram detected pulmonary hypertension (PAPs 40+10 mmHg). A cardiac MRI confirmed a diagnosis of myocarditis [8].

Two nasopharyngeal swabs for SARS-Cov-2 were negative on days 14 and 16 after admission. The patient was discharged in good condition after three weeks of hospitalization, on doxazosine, amlodipine, nebivolol and ramipril 2.5 mg. ARV therapy was changed to TAF/FTC and raltegravir, to minimize possible drug interactions [3].


We have reported the first case of myocarditis during COVID-19 in a person living with HIV. The outcome was positive. Few cases of COVID-19 in HIV-infected patients (reviewed in 3) have been described so far in the literature, and many more will have to be observed to get the full picture of COVID-19 in HIV- coinfected people.


Get the App